(Yahoo! Finance) Mar 26, 2019 - First DARZALEX combination treatment regimen being pursued in the frontline setting for transplant eligible patients with multiple myeloma. The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food...

(Reuters) Mar 21, 2019 - GlaxoSmithKline received a boost for its oncology research on Thursday, as it reported further positive data from a study of its experimental drug for blood cancer. The DREAMM-1 study of patients with relapsed/refractory multiple myeloma confirmed the potential effectiveness of the medicine, GSK said.